LIVZON PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

does not make any representation about the accuracy or completeness of this announcement and expressly disclaims any liability arising out of or in connection with all or any part of this announcement.

We accept no liability for any loss caused by reliance on such content.

Overseas regulatory announcement

This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

This is to set forth the "Livzon Pharmaceutical Group Co., Ltd." published on the website of the Shenzhen Stock Exchange Co., Ltd.'s Announcement on the Profit Distribution Plan for 2025" is for reference only.

By order of the board of directors

Livzon Pharmaceutical Group Co., Ltd. LivzonPharmaceuticalGroupInc.* company secretary Liu Ning

China, Zhuhai March 24, 2026

As of the date of this announcement, the executive director of the company is Mr. Tang Yanggang (vice chairman); the non-executive director of the company is Mr. Zhu Baoguo. Sheng (Chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee director is Ms. Ran Yongmei; and the company’s independence is not

The executive directors are Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie and Ms. Wang Zhiyao.

*Identification only

Securities code: 000513, 01513 Securities abbreviation: Livzon Group, Livzon Pharmaceutical Announcement number: 2026-10

Livzon Pharmaceutical Group Co., Ltd.

Announcement on the 2025 Profit Distribution Plan

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete.

False records, misleading statements or material omissions.

1. Review procedures

On March 24, 2026, Livzon Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") held

The 33rd meeting of the 11th Board of Directors was held and the “Profit Distribution Plan for 2025” was reviewed and approved (Table

The decision was: 9 votes in favor, 0 votes against, 0 abstentions). This profit distribution plan still needs to be submitted to the company

Reviewed by shareholders meeting.

2. Basic information on the profit distribution plan

(1) Basic contents of this profit distribution plan

1. Allocation basis: 2025.
2. According to the provisions of the "Company Law of the People's Republic of China" and the "Articles of Association", the company distributes tax for the year

When the final profits are made, 10% of the profits shall be withdrawn and included in the company's statutory reserve fund. The cumulative amount of the company's statutory reserve fund is

If more than 50% of the company's registered capital is exceeded, no further withdrawals can be made. The opening balance of the company's statutory reserve fund is

477,115,292.03 yuan, which has reached 50% of the company’s registered capital. The company will not withdraw statutory provident fund and

Discretionary Provident Fund. 3. After being audited by Grant Thornton Accounting Firm (Special General Partnership), the company’s 2025 consolidated financial statements are

The net profit belonging to shareholders of the parent company is 2,023,249,327.79 yuan; as of the end of 2025, the company’s consolidated statements

The accumulated undistributed profits at the end of the period were RMB 12,738,196,339.64. The parent company’s accumulated undistributed profits at the end of the period were

The profit was RMB 1,640,234,545.73. According to the provisions of the "Shenzhen Stock Exchange Stock Listing Rules", in accordance with

The specific profit distribution ratio shall be determined based on the lower of the distributable profit in the consolidated statement and the parent company's statement. The upper limit of the company's distributable profits in 2025 is RMB 1,640,234,545.73.

4. According to the "Supervisory Guidelines for Listed Companies No. 3 - Cash Dividends of Listed Companies" and the "Company Articles"

"Process" and other relevant regulations, combined with the company's operating conditions in 2025, in line with the principle of profit distribution and ensuring that the company

Under the premise of normal operations and long-term development, and considering shareholder investment returns, the company’s profit distribution forecast for 2025 is

The case is: based on the total share capital on the equity registration date determined by the implementation of the 2025 profit distribution plan (not

Including the number of shares that have been repurchased but not canceled by the company, the total share capital as of the date of this announcement is 887,907,171 shares), a cash dividend of RMB 14.30 (tax included) will be distributed to all shareholders of the company for every 10 shares. It is expected that

The total amount of cash dividends is RMB 1,269,707,254.53. No bonus shares will be distributed and no capital will be used for this profit distribution.

This reserve is converted into share capital.

5. If this profit distribution plan is approved by the shareholders’ meeting, the company’s cumulative cash dividends for the year will be

The amount is RMB 1,269,707,254.53; this year, cash was used as the consideration and centralized bidding was adopted. The amount of A-share repurchases and on-exchange H-share repurchases conducted through The Stock Exchange of Hong Kong Limited is

RMB 579,540,542.01 yuan. To sum up, the total amount of cash dividends and share repurchases this year is

1,849,247,796.54 yuan, accounting for the current year’s net profit attributable to shareholders of listed companies in the company’s consolidated statements

(2,023,249,327.79 yuan), the proportion is 91.40%.

(2) From the announcement of the profit distribution plan to before its implementation, if there are equity incentive exercise, convertible bond conversion, If the total share capital changes due to share repurchase and other situations, the company will make adjustments based on the principle that the distribution ratio remains unchanged.

Total amount of dividends.

3. Details of cash dividend plan

(1) The company does not encounter other risk warning situations

Cash dividend plan indicators:

Project 2025 2024 2023 Total cash dividends (yuan) 1,269,707,254.53 982,059,732.50 1,247,632,149.02

Total repurchase and cancellation (yuan) 579,540,542.01 831,067,804.65 346,154,428.89

Attributable to shareholders of listed companies 2,023,249,327.79 2,061,095,803.97 1,953,650,833.28 Net profit (yuan)

Accumulated undistributed profits at the end of the year in consolidated statements (yuan) 12,738,196,339.64

Accumulated undistributed profits at the end of the year in the parent company’s statement (yuan) 1,640,234,545.73 Whether the listing has been completed for three complete fiscal years? Yes

Total cumulative cash dividends in the last three fiscal years (yuan) 3,499,399,136.05

Cumulative total repurchase and write-off in the last three fiscal years (yuan) 1,756,762,775.55

Average net profit for the past three fiscal years (yuan) 2,012,665,321.68

Accumulated cash dividends and repurchase notes in the past three fiscal years 5,256,161,911.60 Total sales (yuan)

Whether it touches the "Shenzhen Stock Exchange Stock Listing Rules" The provisions of item (9) of Article 9.8.1 may be implemented. No

Other risk warning situations

(2) Specific instructions that do not involve other risk warning situations

The company’s cumulative cash dividends and repurchases and write-offs in the past three fiscal years totaled RMB 5,256,161,911.60.

It is higher than 30% of the average annual net profit in the last three fiscal years and does not violate the Shenzhen Stock Exchange Stock Listing Regulations. Other risk warning situations may be implemented as specified in Item (9) of Article 9.8.1 of the Rules.

(3) Reasonable explanation of cash dividend plan This profit distribution plan complies with the "Company Law of the People's Republic of China" and "Guidelines for the Supervision of Listed Companies No. 3"

No. - Cash Dividends of Listed Companies" "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 -

Regulations such as "Standardized Operation of Main Board Listed Companies" and "Articles of Association of Livzon Pharmaceutical Group Co., Ltd." shall be fully considered.

Taking into account factors such as the company's profitability in 2025, funding requirements for future development, and shareholder investment returns,

In line with the interests of the company and all shareholders.

The company’s audited trading financial assets and derivative financial assets (hedging) at the end of 2024 and 2025

(excluding hedging instruments), debt investments, other debt investments, other equity instrument investments, other non-current funds

Financing assets, other current assets (value-added tax to be deducted, prepaid taxes, contract acquisition costs, etc.) and operating activities (Excluding related assets) and other financial statement items, the total amount calculated and presented is 651,008,664.50 yuan, respectively.

1,867,643,628.36 yuan, accounting for 2.66% and 7.79% of total assets respectively, both below 50%.

4. Documents available for inspection

(1) The company’s 2025 annual audit report;

(2) Resolution of the 33rd meeting of the 11th board of directors of the company.

Board of Directors of Livzon Pharmaceutical Group Co., Ltd.

March 25, 2026